FUGO and Graphy Ally to Automate High-Volume 3D Printing
- 90% reduction in total cycle times through automation
- Sub-30-micron accuracy with centrifugal 3D printing
- $5 billion projected market value for dental 3D printing in 2026
Experts view this partnership as a transformative step toward scalable, high-precision 3D printing in dental and medical manufacturing, leveraging automation and clinically validated materials to overcome industry bottlenecks.
FUGO and Graphy Ally to Automate High-Volume 3D Printing
GARDENA, CA – January 08, 2026 – In a move poised to reshape the landscape of additive manufacturing, California-based startup FUGO Precision 3D has announced a strategic partnership with South Korean materials innovator Graphy Inc. The collaboration will integrate Graphy's high-performance photopolymer resins into FUGO's novel centrifugal 3D printing platform, a system the company asserts is the world's first to consolidate the entire production workflow—from printing to final curing—into a single, automated cycle.
The announcement comes as FUGO prepares for its official market debut at LMT Lab Day 2026 in Chicago, the dental laboratory industry's largest trade show. By combining groundbreaking hardware with clinically validated materials, the partnership aims to solve one of the most persistent bottlenecks in 3D printing: laborious and time-consuming post-processing. This alliance signals a significant step towards true mass manufacturing capabilities for industries like dental and medical devices, where precision, speed, and biocompatibility are paramount.
A New Spin on Additive Manufacturing
At the heart of this partnership is FUGO's patented centrifugal 3D printing technology. Unlike conventional resin-based methods like stereolithography (SLA) or digital light processing (DLP), which build objects layer-by-layer from the bottom up and require mechanical steps to separate and recoat, FUGO's system utilizes centrifugal force. Parts are printed from the wall of a cylindrical build chamber inwards, a process the company claims enables "layerless" printing with sub-30-micron accuracy at speeds up to ten times faster than traditional printers.
The system's most disruptive feature, however, is its fully integrated workflow. While the current market offers numerous "all-in-one" washing and curing stations as separate companion devices, FUGO's platform is the first to incorporate printing, washing, drying, and post-curing into a single, uninterrupted, and fully automated process within the same machine. This eliminates the need for manual intervention, where technicians would typically move freshly printed parts from the printer to separate baths of isopropyl alcohol and then to a UV curing chamber.
By automating these steps, FUGO aims to slash operational labor and reduce total cycle times by up to 90%. This radical efficiency addresses a major pain point for dental labs and other high-output manufacturers, where post-processing can account for a significant portion of both the cost and time required to produce a final part. The technology promises to deliver production-ready components directly from the machine, a transformative concept for scalable manufacturing.
The Critical Role of Advanced Materials
Hardware innovation alone is not enough to revolutionize regulated industries. The partnership with Graphy underscores the critical importance of material science in achieving clinically viable results. Graphy, a publicly traded company on the KOSDAQ, is a global leader in photopolymer innovation, best known for its patented Shape Memory Aligner (SMA) material.
This collaboration specifically leverages Graphy's biocompatible Class II dental resins. These materials are engineered for applications that involve long-term contact with the human body, such as dentures, crowns, and surgical guides. The credibility of these materials is supported by clinical validation studies, including research published in the peer-reviewed journal Materials in May 2023, which confirmed their high mechanical strength, dimensional stability, and biocompatibility.
When these advanced resins are paired with FUGO's precision centrifugal printing and integrated post-processing, the result is a final part that not only meets but potentially exceeds existing clinical performance standards. The automated, enclosed system ensures a highly controlled and repeatable process, minimizing the risk of contamination or process variability that can occur with manual handling.
"This partnership enables a new class of precision manufacturing," said Alexandr (Sasha) Shkolnik, CTO of FUGO Precision 3D, in the company's official announcement. "We're not only streamlining production - we're elevating the clinical performance standard with each cycle. The combination of hardware innovation and material science sets the stage for true mass manufacturing at scale."
Disrupting a Multi-Billion Dollar Market
The timing of this partnership is strategic, targeting a dental 3D printing market that is experiencing explosive growth. Market analysts project the industry's value to reach approximately $5 billion in 2026, with forecasts showing a compound annual growth rate (CAGR) exceeding 20% over the next decade. This growth is fueled by the increasing adoption of digital dentistry, a rising demand for personalized prosthetics, and an aging population.
Despite this rapid expansion, the industry faces challenges, including the high cost of equipment and a persistent shortage of skilled technicians needed to operate complex digital workflows. FUGO's automated solution is directly positioned as a remedy to these issues. By dramatically reducing the need for hands-on labor and consolidating multiple pieces of equipment into one, the company offers a compelling value proposition for dental labs looking to scale production, improve consistency, and lower their operational overhead.
The alliance with Graphy allows FUGO to enter the market not just with a faster machine, but with a validated, end-to-end solution for producing high-quality, patient-safe dental appliances. This approach could allow labs to transition from producing dozens of parts per day to hundreds, fundamentally changing the economics of dental manufacturing.
Strategic Launchpad to LMT 2026
Ahead of its full commercial release, FUGO is carefully cultivating its market entry. The company is currently selecting partners across North America for an exclusive 90-day early access program. This initiative will allow high-volume dental labs and medical device manufacturers to evaluate the technology in a real-world production environment, providing crucial feedback while giving these early adopters a significant competitive advantage.
This program will culminate in a full-scale launch at LMT Lab Day Chicago in February 2026. The event, widely regarded as the world's premier gathering for the dental laboratory community, provides an ideal stage for FUGO to demonstrate its technology to thousands of key decision-makers. The company has announced plans to run live demonstrations of full print cycles, showcasing the production of multi-color dentures and aligner components directly on the show floor. This public debut will serve as the first major test of whether FUGO's ambitious claims can capture the attention of an industry ripe for disruption.
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →